Skip to Content

Pfizer STN 50 mg (Sutent 50 mg)

Generic Name: sunitinib

Pill imprint Pfizer STN 50 mg has been identified as Sutent 50 mg.

Sutent is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 50 mg is not a controlled substance under the Controlled Substance Act (CSA).

Sutent 50 mg Pfizer STN 50 mg
Sutent 50 mg Pfizer STN 50 mg Front
Sutent 50 mg Pfizer STN 50 mg Back
Sutent 50 mg Pfizer STN 50 mg
Sutent
Generic Name:
sunitinib
Imprint:
Pfizer STN 50 mg
Strength:
50 mg
Color:
Brown
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Pfizer U.S. Pharmaceuticals Group
National Drug Code (NDC):
00069-0980
Inactive Ingredients:
mannitol
croscarmellose sodium
povidone k25
magnesium stearate
gelatin
titanium dioxide
ferric oxide red
ferric oxide yellow
ferrosoferric oxide
shellac
propylene glycol
sodium hydroxide
povidone

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide